Close window

Disclosure according to sec. 85 German Securities Trading Act and Art. 20 MAR for company APONTIS PHARMA AG:

  • The company compiling the analysis or an affiliated company had reached an agreement on the compilation of the research recommendation with the analysed company.
  • Markings in the chart show rating changes by Warburg Research GmbH in the last 12 months. Every marking details the date and closing price on the day of the rating change.
    Recommendation/Target Price History

    Date Recommendation Target Price Close Price Analyst
    24.10.2022 Buy 27.00 EUR 6.58 EUR Christian Ehmann
    12.08.2022 Buy 29.00 EUR 11.10 EUR Christian Ehmann
    11.05.2022 Buy 31.00 EUR 14.00 EUR Christian Ehmann
    07.04.2022 Buy 33.00 EUR 11.05 EUR Christian Ehmann

    Back to main disclaimer